BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 31678273)

  • 41. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.
    Yang Z; Wang X; Yang J; Sun M; Wang Y; Wang X
    Neurotox Res; 2017 Apr; 31(3):334-347. PubMed ID: 27981510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
    Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
    Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.
    Ge P; Yu X; Wang ZC; Lin J
    Asian Pac J Cancer Prev; 2015; 16(9):4071-5. PubMed ID: 25987089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.
    Chan AS; Tsui WY; Chen X; Chu KM; Chan TL; Chan AS; Li R; So S; Yuen ST; Leung SY
    Oncogene; 2003 Oct; 22(44):6946-53. PubMed ID: 14534543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA methylation of the CDC2L1 gene promoter region decreases the expression of the CDK11p58 protein and reduces apoptosis in keloid fibroblasts.
    Zhang G; Guan Q; Chen G; Qian F; Liang J
    Arch Dermatol Res; 2018 Mar; 310(2):107-115. PubMed ID: 29204684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation.
    Tang H; Goldberg E
    J Androl; 2009; 30(2):157-67. PubMed ID: 18930904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview.
    Sobocińska J; Molenda S; Machnik M; Oleksiewicz U
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression.
    Newell-Price J; King P; Clark AJ
    Mol Endocrinol; 2001 Feb; 15(2):338-48. PubMed ID: 11158338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer.
    Gan L; Chen S; Zhong J; Wang X; Lam EK; Liu X; Zhang J; Zhou T; Yu J; Si J; Wang L; Jin H
    PLoS One; 2011 Feb; 6(2):e16916. PubMed ID: 21347233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic organization of the human NFAT5 gene: exon-intron structure of the 14-kb transcript and CpG-island analysis of the promoter region.
    Dalski A; Schwinger E; Zühlke C
    Cytogenet Cell Genet; 2001; 93(3-4):239-41. PubMed ID: 11528118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
    Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
    Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A variety of RNA polymerases II and III-dependent promoter classes is repressed by factors containing the Krüppel-associated/finger preceding box of zinc finger proteins.
    Senatore B; Cafieri A; Di Marino I; Rosati M; Di Nocera PP; Grimaldi G
    Gene; 1999 Jul; 234(2):381-94. PubMed ID: 10395912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoter.
    Xia J; Zhou ZH; Bubien JK; Fuller CM; Markert JM; Mapstone TB; Gillespie GY; Benos DJ
    Gene; 2003 Aug; 313():91-101. PubMed ID: 12957380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.